5Vote!
Red Orbit (Free subscription) | yesterday
Long durations of exposure to formaldehyde used for embalming in the funeral industry were associated with an increased risk of death from myeloid leukemia, according to a new study published online November 20 in the Journal of the National Cancer Institute.Previous studies have shown excess mortality from lymphohematopoietic malignancies and brain cancer in anatomists, pathologists, and funeral industry...
3Vote!
Entertainment and Showbiz! (Free subscription) | yesterday
If patients with acute leukaemia are transplanted with two units of umbilical cord blood (UCB), their risk of the disease recurrence is significantly reduced, according to a new study from the Masonic Cancer Center, University of Minnesota. The finding could change the current medical practice of using one unit of UCB for treatment of patients who [...] Related posts: Breast density linked to increased...
6Vote!
Red Orbit (Free subscription) | yesterday
About the metabolic enzyme IDH1 and its role in cancerRecent research has linked mutations in the metabolic enzyme IDH1 to glioma and other cancers.[2] Approximately 70 percent of gliomas are known to have the IDH1 mutation. Recently, the IDH1 mutation was also shown to be present in a significant percentage of patients with Acute Myeloid Leukemia, another devastating disease.The insight from this...
3Vote!
Medical News Today (Free subscription) | 16 hours ago
A team led by Penn State's Ross Hardison, T. Ming Chu Professor of Biochemistry and Molecular Biology, has taken a large step toward unraveling how regulatory proteins control the production of gene products during development and growth. Working with collaborators including Drs. Mitchell Weiss and Gerd Blobel at Children's Hospital of Philadelphia, they focused specifically on the complex process...
3Vote!
felixqpn | 11/22/2009
Based on the novel "My Sister's Keeper" by Jodi Picoult. Anna is not sick, but she might as well be. By age thirteen, she has undergone countless surgeries, transfusions, and shots so that her older sister, Kate, can somehow fight the leukemia that has plagued her since childhood. The product of preimplantation genetic diagnosis, Anna was conceived as a bone marrow match for Kate - a life
3Vote!
VitaBeat (Free subscription) | 11/20/2009
Long-term exposure to formaldehyde used for embalming increases funeral industry workers' risk of death from myeloid leukemia, according to a new U.S. government study. Researchers in the Division of Cancer Epidemiology and Genetics at the U.S. National Cancer Institute analyzed data on funeral industry workers who died between 1960 and 1986. Information about the workers' work practices and exposure...
3Vote!
Medical News Today (Free subscription) | 11/20/2009
Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies' applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic...
5Vote!
PR News Wire (Free subscription) | 11/19/2009
MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. announced today the dosing of the first patient in a randomized Phase 2B study of AEG35156, a targeted antisense therapeutic in mid-stage development for multiple oncology indications.
5Vote!
Seattle Post-Intelligencer (Free subscription) | 11/18/2009
NEW YORK -- Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration is withholding a decision to expand approval of Rituxan as a leukemia treatment, pending further discussion.
5Vote!
San Fransisco Chronicle (Free subscription) | 11/18/2009
Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration has asked for more information before considering approving Rituxan as a leukemia treatment. The drug is already approved as a treatment for rheumatoid arthritis and... BiogenIdec - Food and Drug Administration - Genentech - Rituximab - Health
4Vote!
Business Wire (Free subscription) | 11/18/2009
SOUTH SAN FRANCISCO, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies’ applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment...
4Vote!
YA Authors Cafe (Free subscription) | 11/18/2009
She always believed he was her destiny—but what if fate has other plans? Enter the realm of The Immortals—and experience the extraordinary #1 New York Times bestselling series that has taken the world by storm. Ever and Damen have traveled through countless past lives—and fought off the world’s darkest enemies—so they could be together forever. But just as their long-awaited...
5Vote!
Breaking News from The Huntsville Times - al.com (Free subscription) | 11/18/2009
Hutch Mohr, a 5-year-old Monrovia boy with acute lymphoblastic leukemia, hopes to be among those participating in the annual "Give thanks. Walk."
5Vote!
The IN VIVO Blog (Free subscription) | 11/18/2009
Friday's announcement that bits of rubber and other detritus were found in vials of five different drugs manufactured at Genzyme's beleaguered Allston Landing plant was worthy of the satirical publication " The Onion "--except that it was true. The picture grew murkier over the weekend, with the arrival of another Form 483 missive from FDA about ongoing manufacturing issues and a complete...
3Vote!
felixqpn | 11/22/2009
Based on the novel "My Sister's Keeper" by Jodi Picoult. Anna is not sick, but she might as well be. By age thirteen, she has undergone countless surgeries, transfusions, and shots so that her older sister, Kate, can somehow fight the leukemia that has plagued her since childhood. The product of preimplantation genetic diagnosis, Anna was conceived as a bone marrow match for Kate - a life and a role
4Vote!
aarkstore | 10/28/2009
Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Therapy Area Pipeline Report contains detailed information on the acute lymphoblastic leukemia or leukemia or chronic lymphocytic leukemia or chronic myelogenous leukemia or acute myelogenous leukemia or hairy cell leukemia drug pipeline. This...
4Vote!
julieadam | 09/11/2009
The news is filled with new discoveries and benefits of stem cell therapy on a daily basis. However, as most stem cell treatments and therapies aren’t yet approved in the U.S., patients are left in a quandry when it comes to potential treatment. However, one of the most commonly performed transplants in the U.S. has been the bone marrow transplant. Since 1968, this treatment has been used to treat...
Videos